Wednesday, November 20, 2013

BMG LABTECH and InvivoSciences, Inc. Collaborate on 3-D Heart Function Application

Representative data collected on the CLARIOstar,
showing the ability to detect physiological changes in heart
function resulting from drug treatment
BMG LABTECH was proud to participate in the announcement of a collaboration with InvivoSciences, Inc. this week. InvivoSciences, Inc. provide novel drug discovery solutions with their engineered stem cell tissues. The collaboration between BMG LABTECH and InvivoSciences, Inc. will focus on a microplate assay which can monitor 3-D heart tissue function in a time-dependent manner by detecting changes in fluorescence that result from calcium flux. This calcium flux, which is a normal part of heart function, is detected by fluorescent calcium-sensing dyes and the heart tissue can then be assessed for the alterations in function that are observed with drug treatment.

As a part of this collaboration BMG LABTECH will have a short presentation during an InvivoSciences sponsored workshop at the Cell Based Assay Summit in Munich, Germany.

In addition, BMG LABTECH and InvivoSciences will co-present a workshop at the Society for Laboratory Automation and Screening (SLAS) conference on January 20th, 2014 in San Diego, CA.

For more information on this collaboration please visit the BMG LABTECH News page on our website.